Cost-effectiveness of smoking cessation and the implications for COPD.

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The cost burden of COPD is substantial for patients and families, payers, and society as a whole. Smoking has been known for decades to be the leading cause of the disease. Numerous studies have been completed to address the cost-effectiveness of programs created to aid smokers in their efforts to quit. Because several assumptions must be made in order to conduct such a study, and because differences in study design are numerous, comparison of data is difficult. However, studies have consistently shown that regardless of the perspective from which the study was completed, or the methods used to help smokers abstain, the interventions are cost-effective. Although no study has been conducted specifically to assess the cost-effectiveness of smoking cessation interventions as they relate directly to patients with COPD, based on current data it can be concluded that smoking cessation programs are cost-effective for this population.

Original languageEnglish
Pages (from-to)279-287
Number of pages9
JournalInternational Journal of COPD
Volume1
Issue number3
DOIs
StatePublished - 2006

Fingerprint

Smoking Cessation
Chronic Obstructive Pulmonary Disease
Cost-Benefit Analysis
Costs and Cost Analysis
Smoking
Population

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health
  • Health Policy

Cite this

Cost-effectiveness of smoking cessation and the implications for COPD. / Faulkner, Michele A.; Lenz, Thomas L.; Stading, Julie A.

In: International Journal of COPD, Vol. 1, No. 3, 2006, p. 279-287.

Research output: Contribution to journalReview article

@article{0698148b3c744f598285e74dfd60b830,
title = "Cost-effectiveness of smoking cessation and the implications for COPD.",
abstract = "The cost burden of COPD is substantial for patients and families, payers, and society as a whole. Smoking has been known for decades to be the leading cause of the disease. Numerous studies have been completed to address the cost-effectiveness of programs created to aid smokers in their efforts to quit. Because several assumptions must be made in order to conduct such a study, and because differences in study design are numerous, comparison of data is difficult. However, studies have consistently shown that regardless of the perspective from which the study was completed, or the methods used to help smokers abstain, the interventions are cost-effective. Although no study has been conducted specifically to assess the cost-effectiveness of smoking cessation interventions as they relate directly to patients with COPD, based on current data it can be concluded that smoking cessation programs are cost-effective for this population.",
author = "Faulkner, {Michele A.} and Lenz, {Thomas L.} and Stading, {Julie A.}",
year = "2006",
doi = "10.2147/copd.2006.1.3.279",
language = "English",
volume = "1",
pages = "279--287",
journal = "International Journal of COPD",
issn = "1176-9106",
publisher = "Dove Medical Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Cost-effectiveness of smoking cessation and the implications for COPD.

AU - Faulkner, Michele A.

AU - Lenz, Thomas L.

AU - Stading, Julie A.

PY - 2006

Y1 - 2006

N2 - The cost burden of COPD is substantial for patients and families, payers, and society as a whole. Smoking has been known for decades to be the leading cause of the disease. Numerous studies have been completed to address the cost-effectiveness of programs created to aid smokers in their efforts to quit. Because several assumptions must be made in order to conduct such a study, and because differences in study design are numerous, comparison of data is difficult. However, studies have consistently shown that regardless of the perspective from which the study was completed, or the methods used to help smokers abstain, the interventions are cost-effective. Although no study has been conducted specifically to assess the cost-effectiveness of smoking cessation interventions as they relate directly to patients with COPD, based on current data it can be concluded that smoking cessation programs are cost-effective for this population.

AB - The cost burden of COPD is substantial for patients and families, payers, and society as a whole. Smoking has been known for decades to be the leading cause of the disease. Numerous studies have been completed to address the cost-effectiveness of programs created to aid smokers in their efforts to quit. Because several assumptions must be made in order to conduct such a study, and because differences in study design are numerous, comparison of data is difficult. However, studies have consistently shown that regardless of the perspective from which the study was completed, or the methods used to help smokers abstain, the interventions are cost-effective. Although no study has been conducted specifically to assess the cost-effectiveness of smoking cessation interventions as they relate directly to patients with COPD, based on current data it can be concluded that smoking cessation programs are cost-effective for this population.

UR - http://www.scopus.com/inward/record.url?scp=36148944047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148944047&partnerID=8YFLogxK

U2 - 10.2147/copd.2006.1.3.279

DO - 10.2147/copd.2006.1.3.279

M3 - Review article

VL - 1

SP - 279

EP - 287

JO - International Journal of COPD

JF - International Journal of COPD

SN - 1176-9106

IS - 3

ER -